Identification of hub genes, non-coding RNAs and pathways in Renal cell carcinoma (RCC): A comprehensive in silico study

Backgrounds: Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults. RCC begins in the renal tubule epithelial cells, essential for blood filtration and urine production. Methods: In this study, we aim to uncover the molecular mechanisms underlying kidney renal clear cell carc...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmad Golestanifar, Hengameh Khedri, Parisa Noorabadi, Mohammadreza Saberiyan
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Biochemistry and Biophysics Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580825000299
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557494043410432
author Ahmad Golestanifar
Hengameh Khedri
Parisa Noorabadi
Mohammadreza Saberiyan
author_facet Ahmad Golestanifar
Hengameh Khedri
Parisa Noorabadi
Mohammadreza Saberiyan
author_sort Ahmad Golestanifar
collection DOAJ
description Backgrounds: Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults. RCC begins in the renal tubule epithelial cells, essential for blood filtration and urine production. Methods: In this study, we aim to uncover the molecular mechanisms underlying kidney renal clear cell carcinoma (KIRC) by analyzing various non-coding RNAs (ncRNAs) and protein-coding genes involved in the disease. Using high-throughput sequencing datasets from the Gene Expression Omnibus (GEO), we identified differentially expressed mRNAs (DEMs), miRNAs (DEMIs), and circRNAs (DECs) in KIRC samples compared to normal kidney tissues. Our approach combined differential expression analysis, functional enrichment through Gene Ontology (GO) and KEGG pathway mapping, and a Protein-Protein Interaction (PPI) network to identify crucial hub genes in KIRC progression. Results: Key findings include the identification of hub genes such as EGFR, FN1, IL6, and ITGAM, which were closely associated with immune responses, cell signaling, and metabolic dysregulation in KIRC. Further analysis indicated that these genes could be potential biomarkers for prognosis and therapeutic targets. We constructed a competitive endogenous RNA (ceRNA) network involving lncRNAs, circRNAs, and miRNAs, suggesting complex regulatory interactions that drive KIRC pathogenesis.Additionally, the study examined drug sensitivity associated with the expression of hub genes, revealing the potential for personalized treatments. Immune cell infiltration patterns showed significant correlations with hub gene expression, highlighting the importance of immune modulation in KIRC. Conclusion: This research provides a foundation for developing targeted therapies and diagnostic biomarkers for KIRC while underscoring the need for experimental validation to confirm these bioinformatics insights.
format Article
id doaj-art-17fc12a7aa734a38b130444e85da658d
institution Kabale University
issn 2405-5808
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Biochemistry and Biophysics Reports
spelling doaj-art-17fc12a7aa734a38b130444e85da658d2025-02-03T04:16:47ZengElsevierBiochemistry and Biophysics Reports2405-58082025-03-0141101942Identification of hub genes, non-coding RNAs and pathways in Renal cell carcinoma (RCC): A comprehensive in silico studyAhmad Golestanifar0Hengameh Khedri1Parisa Noorabadi2Mohammadreza Saberiyan3Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, IranDepartment of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, IranDepartment of Internal Medicine, School of Medicine, Urmia University of Medical sciences, Urmia, Iran; Corresponding author.Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran; Corresponding author. Department of Medical Genetics, School of Medical Sciences, Hormozgan University of Medical Sciences. P.O.Box: 7919693116, Bandar Abbas, Iran.Backgrounds: Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults. RCC begins in the renal tubule epithelial cells, essential for blood filtration and urine production. Methods: In this study, we aim to uncover the molecular mechanisms underlying kidney renal clear cell carcinoma (KIRC) by analyzing various non-coding RNAs (ncRNAs) and protein-coding genes involved in the disease. Using high-throughput sequencing datasets from the Gene Expression Omnibus (GEO), we identified differentially expressed mRNAs (DEMs), miRNAs (DEMIs), and circRNAs (DECs) in KIRC samples compared to normal kidney tissues. Our approach combined differential expression analysis, functional enrichment through Gene Ontology (GO) and KEGG pathway mapping, and a Protein-Protein Interaction (PPI) network to identify crucial hub genes in KIRC progression. Results: Key findings include the identification of hub genes such as EGFR, FN1, IL6, and ITGAM, which were closely associated with immune responses, cell signaling, and metabolic dysregulation in KIRC. Further analysis indicated that these genes could be potential biomarkers for prognosis and therapeutic targets. We constructed a competitive endogenous RNA (ceRNA) network involving lncRNAs, circRNAs, and miRNAs, suggesting complex regulatory interactions that drive KIRC pathogenesis.Additionally, the study examined drug sensitivity associated with the expression of hub genes, revealing the potential for personalized treatments. Immune cell infiltration patterns showed significant correlations with hub gene expression, highlighting the importance of immune modulation in KIRC. Conclusion: This research provides a foundation for developing targeted therapies and diagnostic biomarkers for KIRC while underscoring the need for experimental validation to confirm these bioinformatics insights.http://www.sciencedirect.com/science/article/pii/S2405580825000299Non-coding RNAsRenal cell carcinomaDiagnostic biomarkersProtein-protein interaction (PPI) network
spellingShingle Ahmad Golestanifar
Hengameh Khedri
Parisa Noorabadi
Mohammadreza Saberiyan
Identification of hub genes, non-coding RNAs and pathways in Renal cell carcinoma (RCC): A comprehensive in silico study
Biochemistry and Biophysics Reports
Non-coding RNAs
Renal cell carcinoma
Diagnostic biomarkers
Protein-protein interaction (PPI) network
title Identification of hub genes, non-coding RNAs and pathways in Renal cell carcinoma (RCC): A comprehensive in silico study
title_full Identification of hub genes, non-coding RNAs and pathways in Renal cell carcinoma (RCC): A comprehensive in silico study
title_fullStr Identification of hub genes, non-coding RNAs and pathways in Renal cell carcinoma (RCC): A comprehensive in silico study
title_full_unstemmed Identification of hub genes, non-coding RNAs and pathways in Renal cell carcinoma (RCC): A comprehensive in silico study
title_short Identification of hub genes, non-coding RNAs and pathways in Renal cell carcinoma (RCC): A comprehensive in silico study
title_sort identification of hub genes non coding rnas and pathways in renal cell carcinoma rcc a comprehensive in silico study
topic Non-coding RNAs
Renal cell carcinoma
Diagnostic biomarkers
Protein-protein interaction (PPI) network
url http://www.sciencedirect.com/science/article/pii/S2405580825000299
work_keys_str_mv AT ahmadgolestanifar identificationofhubgenesnoncodingrnasandpathwaysinrenalcellcarcinomarccacomprehensiveinsilicostudy
AT hengamehkhedri identificationofhubgenesnoncodingrnasandpathwaysinrenalcellcarcinomarccacomprehensiveinsilicostudy
AT parisanoorabadi identificationofhubgenesnoncodingrnasandpathwaysinrenalcellcarcinomarccacomprehensiveinsilicostudy
AT mohammadrezasaberiyan identificationofhubgenesnoncodingrnasandpathwaysinrenalcellcarcinomarccacomprehensiveinsilicostudy